oxycodone and paclitaxel
oxycodone has been researched along with paclitaxel in 11 studies
Research
Studies (11)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Antonsson, M; Bengtsson, O; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Jerndal, G; Wan, H; Winiwarter, S | 1 |
| Ahlin, G; Bergström, F; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Rehngren, M; Wan, H | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Coop, A; Eddington, ND; Hassan, HE; Lee, IJ; Myers, AL | 1 |
| Bhattacharyya, J; Chilkoti, A; Hammer, DA; Hassouneh, W; McDaniel, JR; Vargo, KB | 1 |
| Hayashi, Y; Inoue, K; Kubo, K; Kurozumi, K; Matsumoto, H; Nagai, S; Ohkubo, F; Takei, H; Tsuboi, M | 1 |
| Harumiya, M; Iwase, Y; Kanbara, T; Kanemasa, T; Komiya, S; Masumoto, A; Mori, T; Nakamura, A; Sakaguchi, G; Shibasaki, M; Suzuki, T | 1 |
| Ishiyama, T; Jinguu, A; Kikuchi, J; Matsumoto, H; Suzuki, T | 1 |
Reviews
1 review(s) available for oxycodone and paclitaxel
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Other Studies
10 other study(ies) available for oxycodone and paclitaxel
| Article | Year |
|---|---|
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids.
Topics: Animals; Blood-Brain Barrier; Brain; Extracellular Fluid; Humans; Linear Models; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley | 2009 |
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
Topics: Animals; Biological Transport; Brain; Chemical Phenomena; Dialysis; Hydrogen-Ion Concentration; In Vitro Techniques; Lysosomes; Male; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution | 2011 |
Oxycodone induces overexpression of P-glycoprotein (ABCB1) and affects paclitaxel's tissue distribution in Sprague Dawley rats.
Topics: Adenosine Triphosphatases; Analgesics, Opioid; Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Caco-2 Cells; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Drug Interactions; Drug Tolerance; Humans; Male; Mice; Mice, Knockout; Oxycodone; Paclitaxel; Pain Measurement; Rats; Rats, Sprague-Dawley; Spectrophotometry, Ultraviolet; Tissue Distribution; Up-Regulation; Verapamil | 2007 |
Self-assembly of thermally responsive nanoparticles of a genetically encoded peptide polymer by drug conjugation.
Topics: Amino Acid Sequence; Deoxycytidine; Drug Carriers; Gemcitabine; Hydrophobic and Hydrophilic Interactions; Nanoparticles; Oxycodone; Paclitaxel; Peptides; Pharmaceutical Preparations; Polymers; Temperature | 2013 |
[Efficacy and tolerability of controlled-release oxycodone against nab-paclitaxel-induced musculoskeletal pain in breast cancer patients].
Topics: Adult; Aged; Albumins; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Humans; Middle Aged; Musculoskeletal Pain; Oxycodone; Paclitaxel | 2013 |
Establishment of opioid-induced rewarding effects under oxaliplatin- and Paclitaxel-induced neuropathy in rats.
Topics: Analgesics, Opioid; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Fentanyl; Male; Morphine; Neuralgia; Organoplatinum Compounds; Oxaliplatin; Oxycodone; Paclitaxel; Rats, Sprague-Dawley; Receptors, Opioid, mu; Substance-Related Disorders | 2014 |
[A case of stage IV breast cancer with improved cancer pain using bevacizumab and paclitaxel].
Topics: Aged; Analgesics, Opioid; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Female; Humans; Neoplasm Staging; Oxycodone; Paclitaxel; Pain | 2015 |